Kari Tanderup Selected Research

Brachytherapy

2/2022	Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists.
2/2022	Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working Group.
1/2022	Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study.
1/2022	Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study.
1/2022	Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study.
1/2022	Dosimetric impact of target definition in brachytherapy for cervical cancer - Computed tomography and trans rectal ultrasound versus magnetic resonance imaging.
1/2022	Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
1/2022	Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
1/2022	Point-A vs. volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis.
10/2021	Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kari Tanderup Research Topics

Disease

105	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 10/2006
26	Neoplasms (Cancer) 01/2022 - 07/2008
5	Pathologic Constriction (Stenosis) 01/2022 - 10/2003
5	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 10/2014
4	Endometrial Neoplasms (Endometrial Cancer) 02/2022 - 11/2014
4	Diarrhea 01/2022 - 04/2016
2	Fatigue 01/2022 - 01/2018
2	Edema (Dropsy) 10/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2015
2	Pain (Aches) 01/2021 - 04/2016
2	AIDS-Related Complex (ARC) 01/2019 - 11/2017
2	Constipation 01/2018 - 04/2016
2	Carcinoma (Carcinomatosis) 11/2015 - 01/2008
1	Obesity 01/2022
1	Fistula 01/2021
1	Cystitis 01/2021
1	Urinary Incontinence 01/2021
1	Hemorrhage 01/2021
1	Neoplasm Micrometastasis 01/2019
1	Hydronephrosis 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018
1	Colic (Abdominal Cramps) 01/2018
1	Flatulence 01/2018
1	Hot Flashes 01/2018
1	Stress Fractures (Stress Fracture) 01/2017
1	Sigmoid Neoplasms 12/2016
1	Adenocarcinoma 10/2016
1	Rectal Neoplasms (Rectal Cancer) 08/2016
1	Lymphedema (Milroy Disease) 04/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2016
1	Dyspnea (Shortness of Breath) 04/2016
1	Hyperthermia 03/2016
1	Residual Neoplasm 07/2014
1	Margins of Excision 10/2006

Drug/Important Bio-Agent (IBA)

1	4-iodobenzenesulfonamideIBA 01/2022
1	GoldIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	hydroxide ionIBA 07/2015
1	PlasticsIBA 08/2014
1	Contrast MediaIBA 08/2014
1	Aluminum Oxide (Sapphire)IBA 09/2011
1	CarbonIBA 09/2011
1	Stainless Steel (Steel, Stainless)IBA 11/2009
1	TitaniumIBA 11/2009
1	Phenobarbital (Luminal)FDA Link 10/2003

Therapy/Procedure

101	Brachytherapy 02/2022 - 08/2007
46	Radiotherapy 01/2022 - 01/2008
16	Therapeutics 01/2022 - 05/2014
15	Chemoradiotherapy 01/2022 - 04/2011
9	Drug Therapy (Chemotherapy) 01/2021 - 04/2010
4	Aftercare (After-Treatment) 01/2022 - 04/2016
3	Proton Therapy 01/2021 - 11/2017
3	Catheters 12/2016 - 10/2006
2	Image-Guided Radiotherapy 01/2020 - 11/2012
1	Secondary Prevention 01/2022
1	Adjuvant Radiotherapy 01/2021
1	Drug Tapering 07/2013
1	Radiation Dosimeters 09/2011
1	Stents 10/2003